Standard Glass Lining Technology IPO – Review
Standard Glass Lining Technology Limited – one of the top 5 specialised engineering equipment manufacturers for pharmaceutical and chemical sectors in India is planning to raise INR 410.05 Crore via IPO [Fresh Issue 210 Crore + OFS 200.05 Crore]
Standard glass lining ipo share price is INR 133 – 140 per share.
Standard Glass Lining Technology: History
The company was incorporated in the year 2012 and it is a leading manufacturer of engineering equipment for the below-listed sectors in India –
- Pharmaceutical sectors and
- Chemical sectors
The company can manage the entire production process in-house.
Last Article: Indo Farm Equipment Limited IPO Review
Standard Glass Lining Technology: Business
Standard glass lining company is
- one of the top five manufacturers for chemical and pharmaceutical sectors in the country,
- one of India’s top three manufacturers of glass-lined, stainless steel, and nickel alloy-based specialised engineering equipment, and
- one of the top three suppliers of polytetrafluoroethylene (PTFE) lined pipelines and fittings in India.
The Company’s capabilities include –
(1) designing,
(2) engineering,
(3) manufacturing,
(4) assembly,
(5) installation, and commissioning solutions
as well as establishing standard operating procedures for chemical and pharmaceutical manufacturers on a turnkey basis.
Standard Glass Lining Technology: Portfolio
The company’s portfolio comprises core equipment used in the manufacturing of pharmaceutical and chemical products, which can be categorized into –
- Reaction Systems;
- Storage, Separation, and Drying Systems; and
- Plant, Engineering and Services (including other ancillary parts)
Standard Glass Lining Technology: Client
The company has a diversified client base in sectors such as chemicals, beverages, biotechnology, pharmaceutical, paint, food and fertilizer.
Some of its prestigious clients include –
- Aurobindo Pharma Limited,
- Cadila Pharmaceutical Limited,
- Granules India Limited,
- Laurus Labs Limited,
- Natco Pharma Limited,
- Piramal Pharma Limited,
- Suven Pharmaceuticals Limited,
- Tagros Chemicals India Private Limited, and
- Viyash Life Sciences Private Limited
Manufacturing Facilities & Network
The Company operates through its 8 manufacturing facilities located in the state of Telangana and Hyderabad.
It has a distribution network in Andhra Pradesh, Gujarat, Karnataka, Maharashtra, and Tamil Nadu.
Strategies Ahead
- Expand and improve its existing product portfolio and enter into additional end-user industries.
- Expand capacity by increasing the capabilities of its existing manufacturing plants as well as setting up new manufacturing plants.
- Capitalise on increasing demand from international markets to grow its exports.
- Grow inorganically through strategic acquisitions and alliances
Company Promoters
- Nageswara Rao Kandula,
- Kandula Krishna Veni,
- Kandula Ramakrishna,
- Venkata Mohana Rao Katragadda,
- Kudaravalli Punna Rao, and
- M/S S2 Engineering Services
IPO Details
Standard Glass Lining Technology IPO date = 6 Jan to 8 Jan 2025
Minimum Amount = INR 14,980
Face Value (FV) = INR 10
Minimum Bid = 107 Shares
Listing On = NSE, BSE
Book Running Lead Managers
IIFL Securities Limited,
Motilal Oswal Investment Advisors Limited
FINANCIALS
CONCLUSION
FinBlab recommends SUBSCRIBE ratings on Standard Glass Lining Technology IPO
Disclaimer: The contents and data presented here are just for your information & personal use only. While much effort is made to provide the information, I ( Vishal Dalwadi ) or “FinBlab” do not guarantee the accuracy, correctness, completeness or reliability of any information or data displayed herein and shall not be held responsible.
